Skip to main content

Partially hydrolyzed guar gum supplement reduces high-fat diet increased blood lipids and oxidative stress and ameliorates FeCl3-induced acute arterial injury in hamsters


Increased reactive oxygen species (ROS) and hyperlipidemia can promote arterial thrombus. We evaluated the potential of a partially hydrolyzed guar gum (PHGG) as dietary fiber on lipid profiles and FeCl3-induced arterial thrombosis in the high fat-diet fed hamsters. Our in vitro results found that PHGG is efficient to scavenge O2-•, H2O2, and HOCl. High fat-diet increased plasma triglyceride, total cholesterol, LDL, VLDL, methylguanidine and dityrosine level and accelerated FeCl3-induced arterial thrombosis formation (from 463 ± 51 to 303 ± 45 sec). Low dose PHGG supplement significantly decreased the total cholesterol, LDL, methylguanidine and dityrosine level and delayed the time for arterial thrombosis formation (528 ± 75 sec). High dose PHGG supplement decreased the level in triglyceride, total cholesterol, LDL and VLDL and further delayed the time for arterial thrombus (671 ± 36 sec). The increased Bax protein and decreased Bcl-2 and HSP-70 protein expression was found in the carotid and femoral arteries of high fat-diet hamsters. Low and high dose of PHGG supplement decreased Bax expression and increased Bcl-2 and HSP-70 protein expression. We found that FeCl3 significantly enhanced intercellular adhesion molecule-1 and 4-hydroxynonenal expression in the endothelial site of damaged artery after 150-sec FeCl3 stimulation. PHGG supplement decreased the endothelial ICAM-1 and 4-hydroxynonenal expression after 150-sec FeCl3 stimulation. Based on these results, we conclude that PHGG supplement can increase antioxidant protein expression and thus decrease oxidative stress induced arterial injury.


It is generally accepted that excess reactive oxygen species (ROS) production can cause oxidation of biological macromolecules and produce damage to biological systems [15]. The major ROS like O2-., H2O2 and HOCl, which can produce lipid peroxidation products, malonealdehyde and phosphatidylcholine hydroperoxide [3, 6] and protein oxidation, dityrosine and methylguanidine, as indirect indicators of ROS and/or free-radical activity [6, 7]. Locally enhanced vascular production of ROS decreases the bioavailability of nitric oxide, impairs vascular relaxation, and promotes leukocytes and platelet adhesion/aggregation [8]. On the other hand, increased levels of cholesterol or lipid profiles in the plasma is a status called hyperlipidemia, which can lead to serious problems such as coronary heart disease and other cardiovascular diseases [9]. There is evidence that adhesion of monocytes to the endothelium and transformation of macrophages into foam cells, plaque stability, vasomotor function, platelet aggregation and tendency to thrombosis lead to the development of atherosclerosis and coronary artery disease and can be modified by antioxidants [10, 11]. Therefore, a dynamic interaction exists between endothelial and thrombosis/atherogenesis, both of which may be influenced by oxidative stress and lipid profiles. Adhesion of platelet and leukocytes into the vascular endothelial cell by the increased expression of intercellular adhesion molecule-1 (ICAM-1) is a crucial step in thrombosis/atherogenesis [12]. Suppressed expression of ICAM-1 was associated with reduced adherence of monocytes, lymphocytes and platelets to oxidized LDL stimulated endothelial cells [13, 12]. The defense of vascular endothelium against the damage caused by ROS and dyslipidemia is probably an important factor for reduction of thrombotic and atherosclerotic attack [10]. Vascular wall protection can be achieved by preventive attachment to the vascular wall of antioxidants and elimination/neutralization of toxic products after their disproportioning [14, 15].

Lipid-lowering strategy may have a beneficial role in normalizing vascular function and greatly decreasing the frequency of clinical events associated with atherosclerosis, combined with the ability of antioxidants to alleviate vasomotor disturbances in hypercholesterolemia and to slow the progression of atherosclerosis [3]. There is an increase in interest in finding a naturally antioxidant plant-based compound, which could reduce the increased lipid levels in plasma. Guar gum, a galactomannan derived from the cluster bean of Cyamopsis tetragonolobus which is cultivated in India, Pakistan, and the United States, and its enzymatic hydrolysate (partially hydrolysed guar gum, PHGG) shown in Figure 1 have been shown to decrease levels of serum cholesterol and lipids and postprandial blood glucose [16]. The present study was carried out in hamsters adapted to high-fat diet to compare the lipid-lowering effectiveness of PHGG and to examine the impact of PHGG supplement on FeCl3-induced acute arterial injury in the animals. The antioxidant activity and mechanism in PHGG on FeCl3 induced arterial thrombosis was also evaluated in the present study.

Figure 1
figure 1

Chemical structure of partially hydrolysed guar gum (PHGG). The chemical structure of PHGG: mannose: galactose = 2:1.

Methods and materials

Changes of lucigenin- and luminol-enhanced chemiluminescence counts (CL)

We evaluated the antioxidant activity of PHGG on xanthine (0.75 mg kg-1, dissolved in 0.01 N NaOH) and xanthine oxidase (24.8 mU kg-1) enhanced O2-., 0.03% H2O2 induced H2O2 activity, and 0.03% HOCl induced HOCl activity. Xanthine and xanthine oxidase were purchased from Sigma, USA. ROS levels were measured by a CL analyzing system (CLD-110, Tohoku Electronic Industrial, Sendai, Japan) as described previously (7). The system contains a photon detector (Model CLD-110), CL counter (Model CLC-10), water circulator (Model CH-200) and 32 bit IBM personal computer system. A cooler circulator is connected to the model CLD-110 photon detector to keep the temperature at 5°C. The CLD-110 model is extremely sensitive; it is able to detect as little as 10-15 W of radiant energy. The CL was measured in an absolutely dark chamber of the CL analyzing system. We demonstrated that using CL-emitting substance lucigenin (N, N'-dimethyldiacridinium, Sigma, St. Louis, MO, USA) for O2-. or luminol (5-amino-2,3-dihydro-1,4-phthalazinedione, Sigma, St. Louis, MO, USA) for H2O2 or HOCl (hydrogen peroxide, sodium hypochlorite, Sigma, St. Louis, MO, USA) to enhance the CL counts provided similar data to those reported in our previous study [1, 3]. The lucigenin-enhanced CL method provides a reliable assay for superoxide. After 100 s, 1.0 ml of 0.1 mM lucigenin in PBS (pH = 7.4) was mixed with the tested sample. The CL in the tested sample was measured continuously for a total of 600 s. The assay was performed in duplicate for each sample, and the results are expressed as CL counts (10 s)-1. The total amount of CL in 600 s was calculated by integrating the area under the curve. The mean ± S.E.M. CL level for each sample was calculated.


Golden Syrian hamster (Mesocricetus auratus), male 12-week old, 110–120 g body weight were used and were housed at the Experimental Animal Center, National Taiwan University. A group of eight animals (four/cage) were kept in controlled conditions, temperature 25–26°C, relative humidity 60–80% and 12/12 h light/dark cycle (light from 8.00 a.m. to 8.00 p.m.). Food and water were provided ad libitum. The animals with identification marks were acclimatized for 7 days before experiments. All surgical and experimental procedures were approved by National Taiwan University College of Medicine and College of Public Health Institutional Animal Care and Use Committee and are in accordance with the guidelines of the National Science Council of Republic of China (NSC 1997).

The high-fat diet (HF) was prepared by mixing the normal pellet diet with groundnut oil, cholesterol (Sigma), deoxycholesterol (Sigma), and fructose (Sigma) in a ratio of 610 g:300 ml:5 g:5 g:100 g, respectively, to a final weight of 1.0 kg. This homogenous soft cake was molded in the shape of pellets of about 3 g each. The average caloric intake is estimated from the control diet and high fat diet, respectively. Animals of all the groups were fed with HF (10 g/animal) for 4 days before PHGG treatment. The animals had free access to HF and water for 28 days (days 1–28). Subsequently they were randomly divided into four groups (n = 11 each); Group 1: animals received normal powdered rodent diet (control) (purchased from LabDiet, Nutrition International Inc. USA); Group 2:, animals received HF; Group 3 and 4: 0.25 mg (HFLP) and 1.0 mg PHGG (HFHP) were administered in the animals received HF. PHGG was supplied by Taiyo Kagaku Co., Ltd., Japan.

Collection of blood samples and biochemical analysis from plasma

The collection of blood was made on day 28, 2 h after the last PHGG administration. Hamsters (non-fasted) were anesthetized by sodium pentobarbital (50 mg/ml in normal saline), injected i.p. (1 ml/kg body weight). Blood was drawn from the jugular vein and collected in EDTA-coated tubes (3 mg/ml) by centrifugation at 1,500 × g for 5 min at 4°C for the estimation of plasma total cholesterol, triglycerides, and high-density lipoprotein (HDL), LDL, very low-density lipoprotein (VLDL), and cholesterol values were measured [3]. The measurement of lipoprotein(a) [Lp(a)] was performed with a commercial LPA kit (#465360, Beckman Coulter-Array System, Denmark). The analysis of plasma biochemical parameters was performed on an auto-analyzer of Beckman Coulter model, 'Synchron-CX-5 Clinical System' by standard enzymatic methods, and assay kits were purchased from Beckman Coulter International USA.

FeCl3 induced acute arterial thrombosis

All the animals were anesthetized by subcutaneous injection of 1.2 g/kg urethane (Sigma-Aldrich Inc., St. Louis, MO, USA). A PE-50 catheter was catheterized in the femoral vein for intravenous administration of tested saline by an infusion pump (Infors AG, CH-4103, Bottmingen, Switzerland) at a rate of 1.2 ml/min. After arterial isolation, transonic flow probes (Probe# 0.5VBB517, Transonic Systems Inc., Ithaca, NY, USA) for carotid arterial blood flow measurement were applied and were displayed on a small animal blood flow meter (Model 206, Transonic Systems Inc., Ithaca, NY, USA). All the blood flow signals were continuously recorded by an ADI system (PowerLab/16S, ADI Instruments, Pty Ltd, Castle Hill, Australia). The carotid artery was injured as previously described [11] with slight modification. A filter paper (1 mm × 2 mm) soaked with 30% FeCl3 solution (Ferric chloride, Sigma, St. Louis, MO, USA), was applied to the artery for 3 minutes and the cavity was filled with saline immediately [11]. The FeCl3 solution easily diffused into the arterial tissue induced a Fenton reaction mediated endothelial injury (impairment of nitric oxide release) and subsequently induce vascular constriction to reduce arterial blood flow within minutes [11]. The flow rate was monitored and recorded and the time to occlusion (TTO, arterial blood flow decreases to zero) was determined.

4-HNE products and ICAM-1 expression in the carotid artery

We considered that the high levels of FeCl3 via Fenton reaction enhanced ROS might promote the expression of ICAM-1 and the accumulation of lipid peroxides, 4-hydroxynonenal (4-HNE) in the endothelium for induction of thrombosis within minutes. We evaluated the expression of 4-HNE and ICAM-1 after 150 sec of FeCl3 stimulation in four groups of hamsters (n = 3 in each group). 4-hydroxynonenal (4-HNE) [5] and ICAM-1 expression [17] in the OCT-embedded sections of vascular rings were immunostained. On the day of staining, we removed the frozen slides from -20°C and thawed at 25°C for 30 min. After rinsing in 0.2 mol/L of phosphate buffer saline (PBS), the sections were incubated in 3% hydrogen peroxide in 0.2 mol/L of PBS for 30 min, followed by incubation in blocking buffer (5% goat serum, 0.25% Triton-X, 1% dry milk in 0.2 mol/L PBS) for 1 h, followed by the exposure to specific primary antibody. The 30-μm cross sections were stained immunohistochemically for presence of in vivo markers of lipid peroxidation, 4-HNE-protein adducts, by incubation with a polyclonal antibody (Alpha Diagnostic International; San Antonio, TX, USA) and antibody raised against ICAM-1 (R&D Systems, Minneapolis, MN, USA) diluted at 1:50 overnight. The following day, sections were incubated for 2 h at 25°C with biotinylated goat-anti-rabbit secondary antibody (1:200, vector ABC-AP kit; vector Labs, Burlingame, CA, USA). The sections were stained with an avidin-biotinylated horseradish-peroxidase procedure using a commercially available kit (ABC Elite; Vector Laboratories). Finally, the color was developed by the 3'-Amino-9-ethylcarbazole substrate (Vector Laboratories). The 4-HNE and ICAM-1 stains were photographed on an Leica microscope (model DMRD, Leica Microsystems Wetzlar, Wetzlar, Germany). The expressed percentage of endothelial 4-HNE and ICAM-1 expression was analyzed by the curvature of circular stain/360° × 100%. The percentage of 4-HNE and ICAM-1 expression in the vascular ring was calculated as following formula.

Immunoblot analysis of antioxidant- and anti-apoptosis-related proteins

Antibodies raised against mouse anti-human Bcl-2 (Transduction, Bluegrass-Lexington, KY, USA), Bax (Chemicon, Temecula, CA, USA) and primary polyclonal rabbit antihuman HSP-70 (Transduction, Bluegrass-Lexington, KY, USA) antibodies were diluted at 1:400. (BioVision, Mountain View, CA, USA), and β-actin (Sigma) were used. Proteins on SDS-PAGE gels were transferred to nitrocellulose filters and stained as described previously [1]. The density of the band with the appropriate molecular mass was determined semi-quantitatively by densitometry using an image analyzing system (Alpha Innotech, San Leandro, CA). The ratio of HSP70 and Bcl-2 and respective β-actin density was used to compare among groups.

Statistical analyses

All values were expressed as mean ± standard error mean (SEM). Differences within groups were evaluated by paired t-test. One-way analysis of variance was used for establishing differences among groups. Intergroup comparisons were made by Duncan's multiple-range test. Differences were regarded as significant if P < 0.05 was attained.


Effect of PHGG on scavenging O2-., H2O2 and HOCl activity

We first compared the antioxidant O2-., H2O2, HOCl activity of PHGG in 10 μg/mL. We found that the ability in scavenging O2-., H2O2 and HOCl activity by PHGG, catechins, vitamin C and distilled water was displayed in an order of catechins > vitamin C > PHGG > distilled water as a control value (Figure 2).

Figure 2
figure 2

The antioxidant activity against O 2 -, H 2 O 2 , HOCl in control (distilled water), PHGG, catechins and vitamin C is demonstrated. Catechins, vitamin C and PHGG significantly reduced O 2 -, H 2 O 2 , HOCl activity in an order of catechins > vitamin C > PHGG > control. Each test was performed 6 times. * P < 0.05 when compared to the control value.

Effect of PHGG on caloric intake and body weight gain

Our results showed that HF significantly (P < 0.05) increased the caloric intake and increased body weight gain in the HF, HFLP and HFHP groups when compared to the control group. Two dosages of PHGG did not significantly decrease caloric intake and growth of animals fed with HF (Figure 3). However, there is a tendency for HFLP and HFHP in the reduction of caloric intake and body weight gain.

Figure 3
figure 3

Effect of PHGG on carolic intake and the increased body weight in the four groups of animals. Each group was performed in 11 animals. * P < 0.05 when compared to the control value or 0 week, respectively.

PHGG decreased lipid profiles and oxidative stress

The lipid profiles in the four groups of animals are displayed in the Table 1. We found that four weeks of HF significantly increased TG, T-CHO, HDL, LDL and VLDL, but not LP(a) level with comparison to the control group. Low dose of PHGG significantly reduced HF-enhanced T-CHO and LDL level, whereas high dose of PHGG significantly depressed HF-enhanced TG, T-CHO, LDL and VLDL lelvel.

Table 1 Lipid profiles and oxidative stress in the four groups of hamsters.

On the other hand, oxidative stress indicated by methylguanidine and dityrosine is also significantly elevated in the HF group when compared to the control group. HFLP and HFHP efficiently reduced these oxidative markers when compared to the HF group.

PHGG attenuated FeCl3 induced arterial injury

At the indicated time of 150 sec-FeCl3 stimulation, we observed that enhanced 4-HNE (Figure 4B) and ICAM-1 expression (Figure 4F) was noted in the endothelial site of the damaged carotid artery in the HF group when compared to the control group. We found that FeCl3 induced arterial injury evaluated by TTO was 463 ± 51 sec in the control group, 303 ± 45 sec in the HF group, 528 ± 75 sec in the HFLP and 671 ± 36 sec in the HFHP group, respectively (Figure 4I). HF significantly (P < 0.05) promoted the arterial thrombosis formation when compared to the control group. Low and high dose of PHGG significantly attenuated FeCl3 induced arterial injury by the increased TTO.

Figure 4
figure 4

Effect of PHGG on 30% FeCl 3 -induced 4-HNE, ICAM-1 and TTO in the injuried carotid artery of the hamsters with HF diet. Oxidative stress indicated by 4-HNE (A-D) and ICAM-1 (E-H) immunostaining of hamster carotid arterial sections subjected to 150 sec of FeCl3-induced arterial injury. Significantly enhanced endothelial ICAM-1 (brown color in B) and and 4-HNE (brown color in F) are found in HF group subjected to FeCl3 treated carotid artery. The amplified diagram in the right corner was displayed. Carotid arterial 4-HNE and ICAM-1 expression were significantly reduced in HFLP and HFHP groups. FeCl3 induced time to occlusion (TTO) of carotid arteries obtained from control (n = 11), HF (n = 11), HFLP (n = 11) and HFHP (n = 11) groups is indicated in the I. HF shortened TTO, but was reversed by PHGG treatment. *P < 0.05 vs. control group. # P < 0.05 vs. HF group.

PHGG increased Bcl-2 and HSP-70, but decreased Bax protein expression

As shown in Figure 5, we found that after four weeks of HF diet significantly decreased the Bcl-2 and HSP-70 and enhanced Bax protein expression in the carotid artery and femoral artery. The enhanced Bax and decreased Bcl-2 expression significantly amplified the Bax/Bcl-2 ratio and possibly contributed to FeCl3 induced carotid arterial injury. PHGG treatment preserved the decrease in Bcl-2 and HSP-70 expression and diminished the enhancement in Bax expression in the carotid artery and femoral artery. Also, a further increase in PHGG supplement seems to enhance the Bcl-2 and HSP-70 expression in the carotid and femoral arteries.

Figure 5
figure 5

Effect of low and high dosage of PHGG on Bax, Bcl-2, and HSP-70 expression in the carotid artery and femoral artery of HF fed hamsters. HF increased Bax and decreased Bcl-2 and HSP-70 expression in the hamster carotid and femoral arteries. HFLP and HFHP treatment decreased Bax and increased Bcl-2 and HSP-70 expression in both carotid and femoral arteries. *P < 0.05 vs. control group. # P < 0.05 vs. HF group.


We found that an antioxidant O2-., H2O2, HOCl activity was displayed in an order of catechins > vitamin C > PHGG when compared to the water control. The novel biological function of PHGG as a O2-., H2O2, and HOCl scavenger was first demonstrated in the present study. The combined effect of lipid-lowering and antioxidant activity by 4 weeks of PHGG supplement contributes to the reduction of blood lipids and oxidative stress and the delay of arterial thrombus by the upregulation of endogenous antioxidants and downregulation of ICAM-1.

Guar gum with viscous hydrocolloids may reduce the rate of gastric emptying and the diffusion of nutrients to the mucosa of the small intestine and increase cecal output [18]. For example, guar gum changed bile acid pools and intestinal reabsorption to lower cholesterols [19] and decreased trichloroethylene accumulation in the body by reducing trichloroethylene absorption and fat tissue mass [20]. In our study, PHGG supplement seems to have a tendency to depress HF increased caloric intake. However, PHGG supplement didn't significantly decrease body weight gain when compared to the HF group without PHGG supplement. Previous study showed that guar gum in semisolid meal resulted in a more moderate change in blood glucose and positively affected satiety, while general appetite, total energy intake and meal pattern did not differ [21]. Further data also supported there were no significant differences in body weight between control rats and rats fed the guar gum diets [22]. It has been suggested that PHGG with a reduction in viscosity by partial hydrolysis, its efficiency may be greatly diminished [23, 24]. Yet, several reports have indicated that PHGG like guar gum efficiently increases bile acid secretion and leads to a cholesterol-lowering effect in rats fed high-fat diet [21, 24, 25]. The mechanism for an insignificant effect of PHGG on body weight gain requires further investigation in future.

Dietary cholesterol and fat is well known to elicit an accumulation of cholesterol esters and triglycerides in the liver possibly via an enhancement of cholesterol-7α hydroxylase activity for bile acid synthesis, and a suppression of HMG-CoA reductase activity for rate-limiting cholesterol synthesis, contributing to hyperlipidemia [19]. The supplementation of PHGG to lower the intestinal uptake of fat and cholesterol is an interesting strategy to reduce the risk of vascular disease. Our results showed that PHGG significantly decreased blood lipid profiles in the HF fed hamsters. Several mechanisms could be involved. Intake of 3–6% PHGG decreases the bioaccessibility of both fat and cholesterol through the depletion flocculation mechanism to inhibit bile salt induced emulsification and decreases lipolytic activity in the healthy volunteers [25]. PHGG supplement accelerated oxidation of cholesterol toward bile acids accompanied by a marked reduction in hepatic cholesterol and enhanced HMG-CoA reductase activity in the rat [18]. Other notion has also indicated that accelerated cecal bile acid absorption and steroid fecal excretion appear to accompany a greater intestinal bile acid absorption and portal flux to the liver [19]. PHGG can bind the components of micelles in the small intestine: bile acids, but also phospholipids or cholesterol [26]. These mechanisms implicated that PHGG or guar gum contributed to a strong antidyslipidemic potential [2325]. In our study, low dose of PHGG decreased HF enhanced T-CHO and LDL levels, whereas high dose of PHGG further depressed HF-enhanced TG, T-CHO, LDL and VLDL level in the hamsters fed with HF diets. Both low and high dose of PHGG decreased total cholesterol and LDL. High dose of PHGG exerts more efficient in reduction triglyceride, total cholesterol, LDL, and VLDL level. The present study provides important information that 4 weeks of PHGG supplement can ameliorate HF induced hyperlipidemia.

Guar gum administration combats oxidative stress resulting in a trend to lower oxidative modification of LDL [27]. This data implicate that PHGG obtained from guar gum may have a direct antioxidant activity against oxidative stress. We have used a well-established enhanced CL method for measurement of various types of ROS generation [15]. This method has been applied for measurement of ROS production in cultured cells, the whole-blood system, isolated perfused organs, urinary bladder, and kidney in vivo [15]. Our evidence indicated that the enhanced level of O2-., H2O2, HOCl was significantly depressed by PHGG. In addition, we found that the enhanced antioxidant defense mechanism of Bcl-2 and HSP-70 and the depressed apoptotic/oxidant mechanism of Bax expression were noted after 4 weeks of PHGG supplement. Low and high dose of PHGG supplement for four weeks significantly reduced plasma methylguanidine and dityrosine levels, two oxidative stress markers, in the HF fed hamsters. We also found that FeCl3 treatment significantly increased 4-HNE accumulation, a lipid proxidation product, in the endothelial site of carotid artery, indicating oxidative injury existing in the vascular area. PHGG supplement reduced 4-HNE production in the damaged endothelium.

Increased ROS can also trigger the translocation of NF-κB and AP-1 to nucleus and activation of inflammatory cytokines and ICAM-1 that, in turn, contributes to further production of ROS by leukocyte adhesion and inflammation [28]. Enhanced ICAM-1 expression in the endothelial site can increase leukocyte adhesion and platelet aggregation and promoted thrombus formation of the injured vessel [11, 15, 28]. We found that HF fed animals are associated with the increase of oxidative stress and subsequently promoted FeCl3 induced arterial thrombus formation and the impairment of vascular integrity. Our data showed that four weeks of PHGG supplement significantly down regulated ICAM-1 expression in the endothelial site of the FeCl3 treated carotid artery and significantly delayed the time of FeCl3-induced occlusive arterial thrombus in a dose-dependent manner. The beneficial effect could be due to the synergistic effect of a upregulation in antioxidant Bcl-2 and HSP-70 protein, a suppression of endothelial ICAM-1 protein expression, and a reduction in leucocyte and platelet adhesion, consequently leading to the delay of FeCl3 induced thrombus formation in the vascular endothelium of HF fed hamsters.

PHGG supplement decreased cholesterol and lipid levels and oxidative stress and thus has a potential to prevent hypertension and cardiovascular diseases [22, 29, 30]. After 50 days of PHGG administration, attenuation of urinary protein excretion, total cholesterol level and the morphological changes peculiar to diabetic nephropathy were observed in the rats [16]. Moreover, PHGG can delay the elevation of blood sugar and potentially control the blood sugar in the diabetic patients [31]. Based on these evidences, we implicate that PHGG had a potential in reduction of cardiovascular attack.

In conclusion, dietary supplementation with PHGG in hamsters fed with high-fat diet reduced plasma cholesterol and lipid profiles and increased antioxidant Bcl-2 and HSP-70 protein expression in the vessels. High dose of PHGG was more potent than low dose of PHGG in all these effects. Our study further demonstrated that PHGG inhibit FeCl3 enhanced oxidative stress and ICAM-1 expression and delay arterial thrombus formation in hamsters fed with high-fat diet. The clinical implications of these findings are enormous in terms of recommending supplementation of commercial antioxidant diet fibril to patients with vascular disease or those at high risk of developing it.


  1. Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, Hsu SM: De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol. 2001, 12: 973-982.

    CAS  PubMed  Google Scholar 

  2. Chien CT, Yu HJ, Lin TB, Lai MK, Hsu SM: Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS. Am J Physiol Renal Physiol. 2003, 284: F840-851.

    Article  CAS  PubMed  Google Scholar 

  3. Chien CT, Chang WT, Chen HW, Wang TD, Liou SY, Chen TJ, Chang YL, Lee YT, Hsu SM: Ascorbate supplement reduces oxidative stress in dyslipidemic patients undergoing apheresis. Arterioscler Thromb Vasc Biol. 2004, 24: 1111-1117. 10.1161/01.ATV.0000127620.12310.89.

    Article  CAS  PubMed  Google Scholar 

  4. Chien CT, Chang TC, Tsai CY, Shyue SK, Lai MK: Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis. Am J Transplant. 2005, 5: 1194-1203. 10.1111/j.1600-6143.2005.00826.x.

    Article  CAS  PubMed  Google Scholar 

  5. Chien CT, Shyue SK, Lai MK: Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy. Transplantation. 2007, 84: 1183-1190.

    Article  CAS  PubMed  Google Scholar 

  6. Huang KC, Yang CC, Lee KT, Chien CT: Hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water. Kidney Int. 2003, 64: 704-714. 10.1046/j.1523-1755.2003.00118.x.

    Article  CAS  PubMed  Google Scholar 

  7. Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT: Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int. 2006, 69: 706-714. 10.1038/

    Article  CAS  PubMed  Google Scholar 

  8. Hermann M: Cyclooxygenase-2 and nitric oxide. J Cardiovasc Pharmacol. 2006, 7: S21-S25. 10.1097/00005344-200605001-00005.

    Article  Google Scholar 

  9. Simons LA: Additive effect of plant sterol-ester margarine and cerivastatin in lowering low density lipoprotein cholesterol in primary hypercholesterolemia. Am J Cardiol. 2002, 90: 737-740. 10.1016/S0002-9149(02)02600-0.

    Article  CAS  PubMed  Google Scholar 

  10. Leopold JA, Loscalzo J: Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol. 2005, 25: 1332-1340. 10.1161/01.ATV.0000163846.51473.09.

    Article  CAS  PubMed  Google Scholar 

  11. Saldeen T, Li D, Mehta JL: Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol. 1999, 34: 1208-1215. 10.1016/S0735-1097(99)00333-2.

    Article  CAS  PubMed  Google Scholar 

  12. Siennicka A: The effect of short-chain fatty acids on expression of endothelial adhesion molecules stimulated by oxidatively modified LDL. Ann Acad Med Stetin. 2005, 51: 117-126.

    PubMed  Google Scholar 

  13. Ferber P, Moll K, Koschinsky T, Rösen P, Susanto F, Schwippert B, Tschöpe D: High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus. Horm Metab Res. 1999, 31: 665-671. 10.1055/s-2007-978818.

    Article  CAS  PubMed  Google Scholar 

  14. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP, Salvemini D: Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Brit J Pharmacol. 2001, 132: 19-29. 10.1038/sj.bjp.0703775.

    Article  CAS  Google Scholar 

  15. Pratico D: Antioxidants and endothelium protection. Atherosclerosis. 2005, 181: 215-224. 10.1016/j.atherosclerosis.2005.03.005.

    Article  CAS  PubMed  Google Scholar 

  16. Yokozawa T, Nakagawa T, Oya T, Okubo T, Juneja LR: Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy. J Pharm Pharmacol. 2005, 57: 773-780. 10.1211/0022357056154.

    Article  CAS  PubMed  Google Scholar 

  17. Mochida S, Ohno A, Arai M, Tamatani T, Miyasaka M, Fujiwara K: Role of adhesion molecules in the development of massive hepatic necrosis in rats. Hepatology. 1996, 23: 320-328. 10.1002/hep.510230219.

    Article  CAS  PubMed  Google Scholar 

  18. Favier ML, Bost PE, Demigné C, Rémésy C: The cholesterol-lowering effect of guar gum is not the result of a simple diversion of bile acids toward fecal excretion. Lipids. 1997, 32: 953-959. 10.1007/s11745-997-0123-z.

    Article  CAS  PubMed  Google Scholar 

  19. Moriceau S, Besson C, Levrat MA, Moundras C, Rémésy C, Morand C, Demigné C: Cholesterol-lowering effects of guar gum: changes in bile acid pools and intestinal reabsorption. Lipids. 2000, 35: 437-444. 10.1007/s11745-000-542-x.

    Article  CAS  PubMed  Google Scholar 

  20. Nakashima Y, Ikegami S: Guar gum reduces trichloroethylene accumulation in the body by reducing TCE absorption and fat tissue mass. J Agric Food Chem. 2001, 49: 3499-3505. 10.1021/jf001221r.

    Article  CAS  PubMed  Google Scholar 

  21. Kovacs EM, Westerterp-Plantenga MS, Saris WH, Melanson KJ, Goossens I, Geurten P, Brouns F: The effect of guar gum addition to a semisolid meal on appetite related to blood glucose, in dieting men. Eur J Clin Nutr. 2002, 56: 771-778. 10.1038/sj.ejcn.1601407.

    Article  CAS  PubMed  Google Scholar 

  22. Frias AC, Sgarbieri VC: Guar gum effects on food intake, blood serum lipids and glucose levels of Wistar rats. Plant Foods Hum Nutr. 1998, 153: 15-28. 10.1023/A:1008052216477.

    Article  Google Scholar 

  23. Knopp RH, Superko HR, Davidson M, Insull W, Dujovne CA, Kwiterovich PO, Zavoral JH, Graham K, O'Connor RR, Edelman DA: Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med. 1999, 17: 18-23. 10.1016/S0749-3797(99)00039-2.

    Article  CAS  PubMed  Google Scholar 

  24. Levrat-Verny MA, Behr S, Mustad V, Rémésy C, Demigné C: Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption. J Nutr. 2000, 130: 243-248.

    CAS  PubMed  Google Scholar 

  25. Minekus M, Jelier M, Xiao JZ: A fibre cocktail of fenugreek, guar gum and wheat bran reduces oxidative modification of LDL induced by an atherogenic diet in rats. Mol Cell Biochem. 2005, 294: 145-153.

    Google Scholar 

  26. Ebihara K, Schneeman BO: Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. J Nutr. 1989, 119: 1100-1106.

    CAS  PubMed  Google Scholar 

  27. Venkatesan N, Devaraj SN, Devaraj H: A fibre cocktail of fenugreek, guar gum and wheat bran reduces oxidative modification of LDL induced by an atherogenic diet in rats. Mol Cell Biochem. 2007, 294: 145-153. 10.1007/s11010-006-9254-z.

    Article  CAS  PubMed  Google Scholar 

  28. Yu HJ, Lin BR, Lee HS, Shun CT, Yang CC, Lai TY, Chien CT, Hsu SM: Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat livers. Am J Physiol Renal Physiol. 2005, 288: F1005-1014. 10.1152/ajprenal.00223.2004.

    Article  CAS  PubMed  Google Scholar 

  29. Kovacs EM, Westerterp-Plantenga MS, Saris WH, Melanson KJ, Goossens I, Geurten P, Brouns F: Associations between spontaneous meal initiations and blood glucose dynamics in overweight men in negative energy balance. Br J Nutr. 2002, 87: 39-45. 10.1079/BJN2001473.

    Article  CAS  PubMed  Google Scholar 

  30. Yamada K, Tokunaga Y, Ikeda A, Ohkura K, Kaku-Ohkura S, Mamiya S, Lim BO, Tachibana H: Effect of dietary fiber on the lipid metabolism and immune function of aged Sprague-Dawley rats. Biosci Biotechnol Biochem. 2003, 67: 429-433. 10.1271/bbb.67.429.

    Article  CAS  PubMed  Google Scholar 

  31. Nandini CD, Sambaiah K, Salimath PV: Dietary fibres ameliorate decreased synthesis of heparan sulphate in streptozotocin induced diabetic rats. J Nutr Biochem. 2003, 14: 203-210. 10.1016/S0955-2863(03)00007-X.

    Article  CAS  PubMed  Google Scholar 

Download references


This work was supported in part by the National Science Council of the Republic of China (NSC96-2320-B002-007) to Dr. CT Chien and in part by the Kuan-Tien General Hospital Research Funds to Dr. DC Kuo.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Chiang-Ting Chien.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

DCK, SPH, and CTC conceived the hypothesis, contributed to the design and conduct of the study, conducted the statistical analyses, drafted the manuscript and critically revised manuscript. All authors read and approved the final manuscript.

Dar-Chih Kuo, Shih-Ping Hsu contributed equally to this work.

Authors’ original submitted files for images

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Kuo, DC., Hsu, SP. & Chien, CT. Partially hydrolyzed guar gum supplement reduces high-fat diet increased blood lipids and oxidative stress and ameliorates FeCl3-induced acute arterial injury in hamsters. J Biomed Sci 16, 15 (2009).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: